N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility (Q55887376)

Europe PubMed Central

title

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility (English)

0 references

1 reference

1 reference

Michael Berk

5

0 references

Gin Malhi

4

Gin S Malhi

0 references

Olivia M. Dean

2

Olivia Dean

0 references

Seetal Dodd

1

Seetal Dodd

0 references

David L. Copolov

3

Expert Opinion on Biological Therapy

David L Copolov

0 references

language of work or name

English

0 references

publication date

6 November 2008

0 references

published in

0 references

volume

8

0 references

issue

12

0 references

page(s)

1955-1962

0 references

cites work

Drug-induced hepatic disorders. Incidence, management and avoidance

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Weight-based N-acetylcysteine dosing chart to minimise the risk of calculation errors in prescribing and preparing N-acetylcysteine infusions for adults presenting with paracetamol overdose in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Clinical pharmacokinetics of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Glutathione: interorgan translocation, turnover, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Glutathione in defense and signaling: lessons from a small thiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Acetylcysteine for acetaminophen poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-acetylcysteine as a potential antidote and biomonitoring agent of methylmercury exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Drug addiction as a pathology of staged neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

The neural basis of addiction: a pathology of motivation and choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Homocysteine and cognitive decline in healthy elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Oral or intravenous N-acetylcysteine for acetaminophen poisoning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Oxidative Stress in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Is cocaine desire reduced by N-acetylcysteine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Glutathione: a novel treatment target in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Serum S100B and antioxidant enzymes in bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Effect of N-acetyl-L-cysteine on lymphocyte apoptosis, lymphocyte viability, TNF-alpha and IL-8 in HIV-infected patients undergoing anti-retroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Melatonin protects against mercury(II)-induced oxidative tissue damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-acetyl-l-cysteine affords protection against lead-induced cytotoxicity and oxidative stress in human liver carcinoma (HepG2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Oxidative stress and DNA damage induced by cadmium in the human keratinocyte HaCaT cell line: role of glutathione in the resistance to cadmium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

N-acetylcysteine -- passe-partout or much ado about nothing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Rheological assessment of mucolytic agents on sputum of chronic bronchitics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901

Adverse reactions to acetylcysteine and effects of overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220802517901